Jade Biosciences (JBIO) Competitors $10.48 +0.03 (+0.29%) As of 07/8/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsSEC FilingsTrendsBuy This Stock JBIO vs. KZR, OKUR, BDRX, RNTX, KALA, EGRX, MRNS, EYEN, DYAI, and ALLKShould you be buying Jade Biosciences stock or one of its competitors? The main competitors of Jade Biosciences include Kezar Life Sciences (KZR), OnKure Therapeutics (OKUR), Biodexa Pharmaceuticals (BDRX), Rein Therapeutics (RNTX), KALA BIO (KALA), Eagle Pharmaceuticals (EGRX), Marinus Pharmaceuticals (MRNS), Eyenovia (EYEN), Dyadic International (DYAI), and Allakos (ALLK). These companies are all part of the "pharmaceutical products" industry. Jade Biosciences vs. Its Competitors Kezar Life Sciences OnKure Therapeutics Biodexa Pharmaceuticals Rein Therapeutics KALA BIO Eagle Pharmaceuticals Marinus Pharmaceuticals Eyenovia Dyadic International Allakos Jade Biosciences (NASDAQ:JBIO) and Kezar Life Sciences (NASDAQ:KZR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership. Which has more risk & volatility, JBIO or KZR? Jade Biosciences has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Kezar Life Sciences has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Is JBIO or KZR more profitable? Jade Biosciences' return on equity of -60.01% beat Kezar Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Jade BiosciencesN/A -60.01% -54.32% Kezar Life Sciences N/A -61.15%-50.27% Do institutionals & insiders have more ownership in JBIO or KZR? 67.9% of Kezar Life Sciences shares are held by institutional investors. 24.9% of Jade Biosciences shares are held by insiders. Comparatively, 9.3% of Kezar Life Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts recommend JBIO or KZR? Jade Biosciences presently has a consensus target price of $14.00, indicating a potential upside of 33.59%. Kezar Life Sciences has a consensus target price of $39.50, indicating a potential upside of 771.96%. Given Kezar Life Sciences' higher probable upside, analysts plainly believe Kezar Life Sciences is more favorable than Jade Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jade Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Kezar Life Sciences 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media refer more to JBIO or KZR? In the previous week, Jade Biosciences had 3 more articles in the media than Kezar Life Sciences. MarketBeat recorded 5 mentions for Jade Biosciences and 2 mentions for Kezar Life Sciences. Jade Biosciences' average media sentiment score of 0.46 beat Kezar Life Sciences' score of -1.00 indicating that Jade Biosciences is being referred to more favorably in the media. Company Overall Sentiment Jade Biosciences Neutral Kezar Life Sciences Negative Which has higher valuation & earnings, JBIO or KZR? Jade Biosciences has higher earnings, but lower revenue than Kezar Life Sciences. Kezar Life Sciences is trading at a lower price-to-earnings ratio than Jade Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJade BiosciencesN/AN/A-$69.63M-$59.65-0.18Kezar Life Sciences$7M4.73-$83.74M-$10.82-0.42 SummaryJade Biosciences beats Kezar Life Sciences on 8 of the 13 factors compared between the two stocks. Get Jade Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for JBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JBIO vs. The Competition Export to ExcelMetricJade BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.78M$2.88B$5.47B$8.95BDividend YieldN/A2.46%5.25%4.06%P/E Ratio-0.1820.8027.0020.10Price / SalesN/A286.98435.75120.29Price / CashN/A41.1936.8257.86Price / Book0.117.487.985.56Net Income-$69.63M-$55.04M$3.16B$248.40M7 Day Performance-2.96%2.44%2.40%4.67%1 Month PerformanceN/A1.90%2.19%6.64%1 Year PerformanceN/A4.35%33.82%21.31% Jade Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JBIOJade Biosciences2.4416 of 5 stars$10.48+0.3%$14.00+33.6%N/A$8.78MN/A-0.1820News CoverageKZRKezar Life Sciences4.0043 of 5 stars$4.40-3.9%$39.50+797.7%-17.2%$33.46M$7M0.0060Negative NewsOKUROnKure Therapeutics3.1117 of 5 stars$2.40+0.4%$32.33+1,247.2%N/A$32.29MN/A0.00N/ABDRXBiodexa PharmaceuticalsN/A$0.87+0.6%N/AN/A$31.61M$470K0.0020Upcoming EarningsRNTXRein TherapeuticsN/A$1.45+3.6%N/AN/A$31.01MN/A0.009KALAKALA BIO3.4563 of 5 stars$4.84+1.7%$13.50+178.9%-24.2%$30.71M$3.89M0.0030News CoverageHigh Trading VolumeEGRXEagle PharmaceuticalsN/A$2.36-18.6%N/A-45.9%$30.65M$257.55M0.00100MRNSMarinus Pharmaceuticals2.3057 of 5 stars$0.55-0.2%$3.92+613.3%-54.2%$30.32M$30.99M-0.22110EYENEyenovia0.9959 of 5 stars$10.56+1.7%$2.00-81.1%-77.3%$29.92M$60K0.0040Analyst UpgradeDYAIDyadic International1.9819 of 5 stars$0.97-2.0%$6.00+518.6%-33.4%$29.79M$3.49M0.007ALLKAllakos3.0261 of 5 stars$0.33flat$2.00+507.7%N/A$29.74MN/A-0.16190 Related Companies and Tools Related Companies Kezar Life Sciences Competitors OnKure Therapeutics Competitors Biodexa Pharmaceuticals Competitors Rein Therapeutics Competitors KALA BIO Competitors Eagle Pharmaceuticals Competitors Marinus Pharmaceuticals Competitors Eyenovia Competitors Dyadic International Competitors Allakos Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JBIO) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jade Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jade Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JBIO Stock Alerts